| 0 |
HYPONATRAEMIA |
26 |
| 1 |
DIZZINESS |
22 |
| 2 |
MUSCLE SPASMS |
21 |
| 3 |
HYPERKALAEMIA |
19 |
| 4 |
BLOOD POTASSIUM INCREASED |
17 |
| 5 |
BLOOD SODIUM DECREASED |
14 |
| 6 |
GLOMERULAR FILTRATION RATE DECREASED |
14 |
| 7 |
HEADACHE |
14 |
| 8 |
BLOOD PRESSURE INCREASED |
12 |
| 9 |
NAUSEA |
12 |
| 10 |
BLOOD PRESSURE DECREASED |
11 |
| 11 |
HYPOTENSION |
10 |
| 12 |
HYPERTENSION |
9 |
| 13 |
BLOOD CREATININE INCREASED |
7 |
| 14 |
FATIGUE |
7 |
| 15 |
ANXIETY |
6 |
| 16 |
ASTHENIA |
6 |
| 17 |
DIARRHOEA |
6 |
| 18 |
DRUG INEFFECTIVE |
6 |
| 19 |
RASH |
6 |
| 20 |
BLOOD PRESSURE SYSTOLIC DECREASED |
5 |
| 21 |
CHEST PAIN |
5 |
| 22 |
DYSPNOEA |
5 |
| 23 |
VISION BLURRED |
5 |
| 24 |
VOMITING |
5 |
| 25 |
COUGH |
4 |
| 26 |
MALAISE |
4 |
| 27 |
POLLAKIURIA |
4 |
| 28 |
SEIZURE |
4 |
| 29 |
ANGIOEDEMA |
3 |
| 30 |
BLOOD POTASSIUM ABNORMAL |
3 |
| 31 |
BLOOD POTASSIUM DECREASED |
3 |
| 32 |
BLOOD PRESSURE FLUCTUATION |
3 |
| 33 |
DEHYDRATION |
3 |
| 34 |
INSOMNIA |
3 |
| 35 |
OEDEMA PERIPHERAL |
3 |
| 36 |
PRURITUS |
3 |
| 37 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
| 38 |
URTICARIA |
3 |
| 39 |
ABDOMINAL DISTENSION |
2 |
| 40 |
ABDOMINAL PAIN UPPER |
2 |
| 41 |
ALOPECIA |
2 |
| 42 |
ANAEMIA |
2 |
| 43 |
APHASIA |
2 |
| 44 |
ATRIAL FIBRILLATION |
2 |
| 45 |
BALANCE DISORDER |
2 |
| 46 |
BLOOD PRESSURE MEASUREMENT |
2 |
| 47 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
| 48 |
BLOOD UREA INCREASED |
2 |
| 49 |
BRADYCARDIA |
2 |
| 50 |
CEREBROVASCULAR ACCIDENT |
2 |
| 51 |
CHEST DISCOMFORT |
2 |
| 52 |
CHRONIC KIDNEY DISEASE |
2 |
| 53 |
CONDITION AGGRAVATED |
2 |
| 54 |
CONFUSIONAL STATE |
2 |
| 55 |
GASTROINTESTINAL DISORDER |
2 |
| 56 |
HEART RATE DECREASED |
2 |
| 57 |
HEART RATE INCREASED |
2 |
| 58 |
HYPERHIDROSIS |
2 |
| 59 |
ILLNESS |
2 |
| 60 |
MOOD ALTERED |
2 |
| 61 |
MUSCULAR WEAKNESS |
2 |
| 62 |
MYALGIA |
2 |
| 63 |
OFF LABEL USE |
2 |
| 64 |
OROPHARYNGEAL PAIN |
2 |
| 65 |
PERSONALITY CHANGE |
2 |
| 66 |
PRODUCT DOSE OMISSION ISSUE |
2 |
| 67 |
RENAL IMPAIRMENT |
2 |
| 68 |
THERAPY CESSATION |
2 |
| 69 |
VISUAL IMPAIRMENT |
2 |
| 70 |
ABDOMINAL PAIN |
1 |
| 71 |
ACCIDENTAL OVERDOSE |
1 |
| 72 |
ACUTE KIDNEY INJURY |
1 |
| 73 |
AGITATION |
1 |
| 74 |
ANGER |
1 |
| 75 |
ARRHYTHMIA |
1 |
| 76 |
ATRIAL TACHYCARDIA |
1 |
| 77 |
BACK PAIN |
1 |
| 78 |
BLINDNESS |
1 |
| 79 |
BLOOD CHOLESTEROL INCREASED |
1 |
| 80 |
BLOOD CREATININE ABNORMAL |
1 |
| 81 |
BLOOD PRESSURE ABNORMAL |
1 |
| 82 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
| 83 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
1 |
| 84 |
BLOOD PRESSURE SYSTOLIC |
1 |
| 85 |
BLOOD SODIUM INCREASED |
1 |
| 86 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
| 87 |
BLOOD UREA ABNORMAL |
1 |
| 88 |
BLOOD URINE PRESENT |
1 |
| 89 |
BRAIN FOG |
1 |
| 90 |
BREAST CANCER |
1 |
| 91 |
BREAST PAIN |
1 |
| 92 |
CARDIAC FLUTTER |
1 |
| 93 |
CARDIOMEGALY |
1 |
| 94 |
COLITIS |
1 |
| 95 |
CONSTIPATION |
1 |
| 96 |
CRYING |
1 |
| 97 |
DEATH |
1 |
| 98 |
DEPRESSION |
1 |
| 99 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
| 100 |
DISORIENTATION |
1 |
| 101 |
DIVERTICULITIS |
1 |
| 102 |
DRUG HYPERSENSITIVITY |
1 |
| 103 |
DYSARTHRIA |
1 |
| 104 |
DYSPHAGIA |
1 |
| 105 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
| 106 |
EPISTAXIS |
1 |
| 107 |
EXTRASYSTOLES |
1 |
| 108 |
EYE SWELLING |
1 |
| 109 |
EYELID PTOSIS |
1 |
| 110 |
FALL |
1 |
| 111 |
FEELING ABNORMAL |
1 |
| 112 |
FLANK PAIN |
1 |
| 113 |
FLATULENCE |
1 |
| 114 |
FLUID RETENTION |
1 |
| 115 |
FLUSHING |
1 |
| 116 |
GAIT INABILITY |
1 |
| 117 |
GENERALISED OEDEMA |
1 |
| 118 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
| 119 |
GOUT |
1 |
| 120 |
HALLUCINATION |
1 |
| 121 |
HOT FLUSH |
1 |
| 122 |
HYPERALDOSTERONISM |
1 |
| 123 |
HYPERSENSITIVITY |
1 |
| 124 |
HYPERTENSIVE CRISIS |
1 |
| 125 |
HYPOAESTHESIA |
1 |
| 126 |
HYPOKALAEMIA |
1 |
| 127 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
| 128 |
INTENTIONAL UNDERDOSE |
1 |
| 129 |
LABORATORY TEST ABNORMAL |
1 |
| 130 |
LACUNAR INFARCTION |
1 |
| 131 |
LDL/HDL RATIO INCREASED |
1 |
| 132 |
LIP SWELLING |
1 |
| 133 |
LIPASE INCREASED |
1 |
| 134 |
LOSS OF CONSCIOUSNESS |
1 |
| 135 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
| 136 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
| 137 |
METAMORPHOPSIA |
1 |
| 138 |
MOTOR DYSFUNCTION |
1 |
| 139 |
MULTIPLE DRUG THERAPY |
1 |
| 140 |
MUSCLE TIGHTNESS |
1 |
| 141 |
MUSCULOSKELETAL STIFFNESS |
1 |
| 142 |
NECK PAIN |
1 |
| 143 |
NEPHROPATHY TOXIC |
1 |
| 144 |
NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED |
1 |
| 145 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
| 146 |
OCULAR DISCOMFORT |
1 |
| 147 |
OEDEMA |
1 |
| 148 |
PAIN |
1 |
| 149 |
PAIN IN EXTREMITY |
1 |
| 150 |
PALPITATIONS |
1 |
| 151 |
PANCREATITIS |
1 |
| 152 |
PARAESTHESIA ORAL |
1 |
| 153 |
PERIPHERAL SWELLING |
1 |
| 154 |
PHOTOPHOBIA |
1 |
| 155 |
PNEUMONIA |
1 |
| 156 |
PRODUCT AVAILABILITY ISSUE |
1 |
| 157 |
PRODUCT DISTRIBUTION ISSUE |
1 |
| 158 |
PRODUCT USE ISSUE |
1 |
| 159 |
RENAL DISORDER |
1 |
| 160 |
SECONDARY HYPERTENSION |
1 |
| 161 |
SKIN DISORDER |
1 |
| 162 |
SKIN ODOUR ABNORMAL |
1 |
| 163 |
SLEEP APNOEA SYNDROME |
1 |
| 164 |
SLUGGISHNESS |
1 |
| 165 |
SOMNOLENCE |
1 |
| 166 |
SPEECH DISORDER |
1 |
| 167 |
SWELLING FACE |
1 |
| 168 |
SWOLLEN TONGUE |
1 |
| 169 |
SYMPATHOMIMETIC EFFECT |
1 |
| 170 |
SYNOVIAL CYST |
1 |
| 171 |
THERAPY CHANGE |
1 |
| 172 |
TINNITUS |
1 |
| 173 |
TREATMENT NONCOMPLIANCE |
1 |
| 174 |
TYPE 2 DIABETES MELLITUS |
1 |
| 175 |
URINARY INCONTINENCE |
1 |
| 176 |
VERTIGO |
1 |
| 177 |
VIRAL INFECTION |
1 |
| 178 |
WEIGHT DECREASED |
1 |
| 179 |
WEIGHT INCREASED |
1 |